A shareholder of BATRA, identified as Jill Robinson, has filed a Form 144 indicating an intention to sell 20,000 shares of Series C Common Stock through UBS Financial Services on NASDAQ at an aggregate market value of $800,028.
The shares are scheduled for approximate sale on February 2, 2026 and were acquired the same day via a cash exercise of stock options for 20,000 shares. The issuer had 51,627,382 shares outstanding of the same class at the time referenced. Robinson also sold Series C Common shares in three prior transactions over the past three months, with individual sales of 20,000, 6,875 and 3,830 shares.
The Vanguard Group has filed an amended Schedule 13G reporting beneficial ownership of 733,932 shares of Atlanta Braves Holdings Inc common stock, representing 7.11% of the class as of the event date of 12/31/2025.
Vanguard reports shared voting power over 144,675 shares and shared dispositive power over all 733,932 shares, with no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
The filing also notes that on 01/12/2026 Vanguard underwent an internal realignment, after which certain subsidiaries or business divisions with beneficial ownership will report on a disaggregated basis. Vanguard’s clients, including registered investment companies and other managed accounts, have rights to dividends or sale proceeds, but no single other person has more than a 5% interest in these securities.
The Vanguard Group reported beneficial ownership of 2,789,081 shares of Atlanta Braves Holdings Inc. common stock, representing 5.4% of the class as of the event date 12/31/2025.
Vanguard reports shared voting power over 326,604 shares and shared dispositive power over all 2,789,081 shares, with no sole voting or dispositive power. The shares are held on behalf of Vanguard’s clients, none of whom individually owns more than 5% of the class. Vanguard notes an internal realignment effective 01/12/2026, after which certain subsidiaries are expected to report beneficial ownership separately.
Reporting persons including GAMCO Investors, Associated Capital Group, GGCP Inc., and Mario J. Gabelli disclosed multiple sales of Atlanta Braves Holdings, Inc. Series A common stock in mid-September 2025. Reported transactions include an 800-share sale on 09/18/2025 at $45.4888 and a 1,100-share sale on 09/19/2025 at $45.1945, plus additional dispositions or indirect ownership adjustments totaling at least 98,452 shares across several entries. Post-transaction beneficial ownership amounts shown include 2,900 shares and 1,800 shares for specific entries, with other blocks held indirectly by named investment partnerships and entities. The filings note disgorgement payments to the issuer for the two sales and explain that reported beneficial ownership reflects total holdings of entities exceeding the reporting persons' direct pecuniary interests.
Gregory John Heller, EVP, CLO & Secretary of Atlanta Braves Holdings, Inc. (BATRK), exercised options and sold shares on 08/21/2025. He exercised a stock option with a $27.18 exercise price to acquire 60,000 shares of Series C common stock and immediately sold 60,000 shares at a weighted average sale price of $43.45, with the sale price range reported as $43.09 to $43.70. After these transactions he beneficially owned 14,876 shares of Series C common stock directly and 80,263 shares through previously held derivative securities or other holdings.
The Form 4 was signed by an attorney-in-fact on 08/22/2025 and discloses the option grant’s original grant date (12/10/2023) and option expiration date (12/10/2027). The filing notes the reported sale price is a weighted average and that detailed per-price sale breakdowns are available upon regulatory request.
Atlanta Braves Holdings, Inc. (BATRK) filed a Form 144 notifying the proposed sale of 60,000 Series C common shares through UBS Financial Services on 08/21/2025 with an aggregate market value of $2,613,000. The shares were acquired the same day via a stock option exercise from Atlanta Braves Holdings, Inc., and payment was recorded on 08/21/2025. There were no securities sold by this person in the past three months. The filing represents a routine insider disposition reported under Rule 144 to comply with securities-sale reporting requirements.
Jill L. Robinson, EVP, CFO & Treasurer of Atlanta Braves Holdings, Inc. (BATRK), reported transactions dated 08/15/2025. She exercised a stock option to acquire 40,000 Series C shares at an exercise price of $27.18, which increased her reported beneficial ownership to 108,755 shares. On the same date she sold 40,000 Series C shares under a Rule 10b5-1 sales plan adopted May 15, 2025, at a weighted average sale price of $43.82 (range $43.68 to $44.12), leaving 68,755 Series C shares beneficially owned after the sale. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
Atlanta Braves Holdings, Inc. (BATRK) reported a Rule 144 notice for the proposed sale of 40,000 shares of Series C common stock through UBS Financial Services on NASDAQ, with an aggregate market value of $1,760,800.00. The filing shows the same 40,000 shares were acquired and paid for on 08/15/2025 by exercise of stock options and paid in cash, and no sales by the reporting person were reported in the prior three months.
The notice includes the standard representation that the seller does not possess undisclosed material adverse information. Outstanding shares are listed as 51,459,265, which provides context for the size of the transaction versus the company’s share base.